Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 11 days 21 hours 55 mins 21 secs SAVE YOUR SEAT!

The CAR-T cell therapy workflow

10 Jun 2019
Clinical

Find out more about the CAR-T cell therapy workflow in this informative infographic from Bio-Rad Laboratories (CA, USA). Discover some of the challenges associated with CAR-T cell R&D as well as technologies and reagents used for bioanalytical analysis.

CAR-T infographic (3)

CLICK HERE TO DOWNLOAD THE INFOGRAPHIC

Top content

  • How blockchain and AI are transforming data integrity in bioanalysis
  • Onsite media partners confirmed for PharmSci 360 2025
  • AAPS PharmSci 360 2025: what can conference attendees look forward to?

Related tags

antibodies Bio-rad CAR-T cell therapy
Previous article Next article

Related articles

24 SEP 2018 GENERAL INTEREST
Poster: novel approach to immunogenicity testing for therapeutics with high prevalence of pre-existing antibodies
How Treg cells impact CAR-T therapy
21 MAY 2024 INTERVIEWS
How Treg cells impact CAR-T therapy: insights from the Cancer Correlative Science Unit
10 MAR 2023 NEWS
NHS centre opening in the UK for revolutionary cell and gene therapies
13 MAR 2019 JOURNAL ARTICLES
Flow cytometry in cell-based pharmacokinetics or cellular kinetics in adoptive cell therapy
28 APR 2020 CLINICAL
COVID-19 and microsampling: from patient-centric testing to drug development and beyond
5 AUG 2021 NEWS
Antibody provider Atlas Antibodies acquires antibody expression servicer evitria
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone